Drug intelligence / Profile preview

Angiotensinamide

Development stage
Unknown
Modality
Peptides, Small Molecules
Administration
Intravenous
01

Overview

Angiotensinamide is a synthetic octapeptide derivative of bovine angiotensin II and acts as a potent vasoconstrictor and cardiac stimulant. It is primarily used for the treatment of severe hypotension unresponsive to traditional pressor agents. The drug increases blood pressure by causing vasoconstriction through direct action on vascular smooth muscle, especially in small caliber arterioles. Angiotensinamide does not have a direct effect on the heart or cause arrhythmias at therapeutic doses. Its effects are short-lived due to rapid enzymatic inactivation in the bloodstream but can be controlled by adjusting infusion rates. Mechanistically, it exerts its action via agonism at the angiotensin II receptor type 1 (AT1), leading to increased peripheral resistance and elevated blood pressure[1][3][4][5].

Brand names
HypertensineIpertensina
Other names
angiotensin amideANGIOTENSINAMIDE
02

Targets

AGTR1 (Angiotensin II Type-1 receptor)

Beyond the preview

Go deeper on Angiotensinamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angiotensinamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call